This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Metabolic myopathy in thyrotoxicosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The features of the myopathy associated with thyrotoxicosis include muscle weakness and wasting, often affecting the limb girdles, and normal creatinine kinase. In males, usually orientals, a rare form of hypokalaemic periodic paralysis occurs causing truncal and limb weakness.

Myasthenia gravis is associated with autoimmune thyroiditis and occasionally complicates hyperthyroidism; conversely, myasthenia gravis may be exacerbated by thyrotoxicosis.

The metabolic myopathy which may complicate Graves disease is caused by enlargement of the extraocular muscles due to infiltration with mucopolysaccharide, fat, inflammatory cells and eventually fibrosis.


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.